Results 151 to 160 of about 342,419 (394)
This study presents the light sheet fluorescence microscopy (LSFM) as a tool for 3D‐imaging of whole skeletal muscle to reveal satellite cells (SCs), the muscle stem cells that activate following damage to repair injured tissue. After tissue clearing and whole‐mount staining process aimed to enable optical access and specific cell labeling (1), murine ...
Rachele Garella +11 more
wiley +1 more source
PATHOLOGY OF PSEUDOHYPERTROPHIC MUSCULAR DYSTROPHY [PDF]
O. P. Johnstone
openalex +1 more source
Association of Laryngeal Dystonia With Common Neurologic Disorders
ABSTRACT Objective Laryngeal dystonia is a heterogenous disorder consisting of involuntary spasms of laryngeal muscles. There are multiple forms including adductor, abductor, and mixed phenotypes. The disorder is thought to be multifactorial, with various reported associations with family history of dystonia or movement disorders.
Brandon LaBarge +2 more
wiley +1 more source
Diagnosis, Pathogenesis and Treatment of Muscular Dystrophy
Muscular dystrophies are a group of inherited genetic disorders that involve an ever-growing number of genes [...]
Manuela Bozzi
doaj +1 more source
Cases of Pseudo-Hypertrophic Paralysis and other Forms of Progressive Muscular Dystrophy [PDF]
Jelliffe
openalex +1 more source
This review highlights synthesis routes, performance optimisation, and applications of fluoropolymers/ZnO nanocomposites, offering valuable insights into piezoelectricity optimisation of materials that empower next‐generation sensors, actuators, and sustainable energy solutions. ABSTRACT Piezoelectric materials convert mechanical energy into electrical
Daphne Mary John +8 more
wiley +1 more source
Case of Pseudo-Hypertrophic Muscular Dystrophy Associated with Amentia [PDF]
E. G. Fearnsides
openalex +1 more source
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori +15 more
wiley +1 more source
Abstract Background Current clinical scales that track disease progression are more tailored to spasticity or ataxia, with limited sensitivity to change. Objectives The aim was to develop a sensitive and valid scale specifically geared towards optimized sensitivity to change and adapted to patients presenting with both spasticity and ataxia.
Cécile Di Folco +37 more
wiley +1 more source

